(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






2333 Result: Design

Kitov Provides Further Update on Formal Investigation by Israeli Securities Authority

February 09th, 2017

Tel Aviv, Israel / CRWE PRESS RELEASE / February 9, 2017 - Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, in response to requests made by the NASDAQ Stock Market, today provided a further upda. Read more

BlackBerry Announces its Next Major Mobile Software Licensing Agreement with Optiemus in India

February 06th, 2017

DELHI, INDIA / CRWE PRESS RELEASE / Feb. 5, 2017 - BlackBerry Limited (NASDAQ:BBRY)(TSX:BB), a global software leader in securing, connecting and mobilizing enterprises, is announcing its next major agreement to license BlackBerry software and servic. Read more

EyeGate Pharma Announces Positive Top-line Data from First-in-Human Pilot Trial of Ocular Bandage Gel in Corneal Epithelial Defects

January 30th, 2017

Company Plans to Continue Development with Next Controlled Trial Q2 2017 WALTHAM, Mass. / CRWE PRESS RELEASE / January 30, 2017 - EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a specialty pharma. Read more

Fuel Tech Awarded Air Pollution Control Orders Totaling $5.0 Million

January 30th, 2017

WARRENVILLE, Ill. / CRWE PRESS RELEASE / January 30, 2017 - Fuel Tech, Inc. (NASDAQ:FTEK), a world leader in advanced engineering solutions for the optimization of combustion systems and emissions control in utility and industrial applications, today. Read more

Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen

January 17th, 2017

* Biogen will pay Forward a non-refundable cash fee of $1.25 billion * Forward may be eligible to receive royalties of 10% of net sales of Tecfidera beginning in 2021, and of 20% of net sales beginning in 2029, depending on the outcome of certain . Read more

Transgenomic Announces Leading Clinical Laboratory Services Provider LifeLabs Selects ICE COLD-PCR as its Mutation Enrichment Platform

January 12th, 2017

Three-Year Renewable Agreement Also Includes Non-Exclusive License to ICP in Canada New Patent Has Issued Covering ICE COLD-PCR Technology in Canada OMAHA, Neb. / CRWE PRESS RELEASE / January 12, 2017 - Transgenomic, Inc. (TBIO) (NASDAQ: . Read more

NOVADAQ Announces Preliminary Unaudited Fourth Quarter 2016 Revenue and Issues 2017 Revenue Guidance

January 11th, 2017

Secures up to $60 million in financing from Midcap Financial Toronto, Ontario / CRWE PRESS RELEASE / January 10, 2017 - NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence . Read more

BlackBerry QNX Launches its Most Advanced and Secure Embedded Software Platform for Autonomous Drive and Connected Cars

January 04th, 2017

LAS VEGAS, NEVADA / CRWE PRESS RELEASE / Jan. 4, 2017 - International CES 2017, LVCC North Hall, Booth 7029 - BlackBerry Limited (NASDAQ:BBRY) (TSX:BB) today announced its most advanced and secure embedded operating system (OS) for the automotive ind. Read more

Pluristem and New York Blood Center to Collaborate in Evaluating PLX-R18 as an Adjuvant Therapy to Umbilical Cord Blood Transplantation, Winning $900,000 Funding From BIRD

December 27th, 2016

* Prior research has suggested that PLX-R18 helps cord blood cells to engraft more rapidly and effectively * Grant of $900,000 from Israel-U.S. Binational Industrial Research and Development Foundation (BIRD) to fund the research * Constitutes a 3r. Read more

Bombardier to Build 28 Additional SkyTrain Vehicles for TransLink in Vancouver

December 19th, 2016

* Option exercised from base contract signed in 2012 * INNOVIA Metro 300 to add capacity for newest SkyTrain expansion lines * Highlights Bombardier’s global leadership in supply of automated metro systems Vancouver, BC / CRWE PRESS RELEAS. Read more

xG Technology Signs Final Definitive Business Purchase Agreement to Acquire Vislink Communication Systems

December 19th, 2016

Sarasota, Florida / CRWE PRESS RELEASE / December 19, 2016 - xG Technology, Inc. (“xG”) (Nasdaq: XGTI, XGTIW), a leader in providing critical wireless communications for use in challenging operating environments, is pleased to announ. Read more

Bombardier Announces 2017 Guidance, Targeting Strong Earnings Growth and FCF Improvement

December 14th, 2016

* Targets EBIT growth before special items(1) of approximately 50%, to $530 million - $630 million * Anticipates year-over-year free cash flow usage(1) improvement by approximately $400 million, to $750 million - $1.0 billion * Expects low sing. Read more

vTv Therapeutics Announces Positive Topline Results from Phase 2 Study of TTP273 in Type 2 Diabetes

December 14th, 2016

Oral small molecule GLP-1 receptor agonist met primary endpoint Company’s second successful Phase 2 diabetes trial in 2016 High Point, North Carolina / CRWE PRESS RELEASE / December 14, 2016 - vTv Therapeutics Inc. (vTv) (Nasdaq: VTVT) to. Read more

Anavex Life Sciences Announces 12-Month Data of ANAVEX 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer's Disease Patients

December 08th, 2016

Data presentation at CTAD 2016 NEW YORK, NY / CRWE PRESS RELEASE / December 8, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL) today announced a positive 57-week update from its . Read more

Pluristem's PLX-R18 Advances into Second Cohort of Dose Selection Study for Treatment of Acute Radiation Syndrome

December 06th, 2016

* NIH’s NIAID completes first cohort of dose selection study * Data from completed study expected in first half of 2017 * Upon determining the optimal dose, a pivotal trial could be conducted to support marketing authorization of PLX-R18 for . Read more

Load More Content